CARR vs DMAC · P/E 43, rev $5.15B vs $157.4M cap
Carrier Global Corp (CARR) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
DMAC does not have a complete income-statement cache yet.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CARR and DMAC stock pages for the full models.
Not investment advice.